Post Profile






See more about: Spectrum Pharmaceuticals

Related Posts


Down 35%! Spectrum Pharmaceuticals, Inc. (SPPI) Is a Biotech Trainwreck: Sagent Pharmaceuticals Inc (SGNT), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Business & Finance / Investing : Insider Monkey

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is hurting today after dialing back guidance for the year. Apparently the increased production by Sagent Pharmaceuticals Inc. (NASDAQ:SGNT) of generic leucovorin, a less purified version ...

Spectrum Pharmaceuticals, Inc. (SPPI): A Reacquired Drug Lottery Ticket

Business & Finance / Investing : Insider Monkey

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has worked some magic with acquisitions, driving sales of forgotten cancer drugs higher. Let’s see if it can do the same for its newest (re)acquisition. First, the biotech has to get the ...

Spectrum Pharmaceuticals, Inc. (SPPI): Is This Biotech for Sale?

Business & Finance / Investing : Insider Monkey

For the last five years, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) CEO Rajesh Shrotriya has always insisted that Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was an acquisitive company, rather than “for sale”. But after a rough 2...

Spectrum Pharmaceuticals Completes Enrollment In Second Of Two Phase 3 Pivotal Trials For Apaziquone In Non-Muscle Invasive Bladder Cancer

Health : Medical News Today

Spectrum Pharmaceuticals (NasdaqGM: SPPI) today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invas...

Spectrum bladder cancer drug not effective: U.S. FDA panel

Health : Reuters: Health

(Reuters) - Spectrum Pharmaceuticals Inc's experimental bladder cancer treatment apaziquone is not effective in delaying the time to recurrence of the disease, an advisory committee to the U.S. Food and Drug Administration concluded...

Comments


Copyright © 2016 Regator, LLC